Alnylam Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$314.04(as of Mar 13, 2:27 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Alnylam Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$314.04
Ticker SymbolALNY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees2,500
CountyUSA
Market Cap$42,496.4M
EBIDTA557.2M
10-Day Moving Average322.87
P/E Ratio137.79
20-Day Moving Average325.66
Forward P/E Ratio34.97
50-Day Moving Average348.52
Earnings per Share2.34
200-Day Moving Average391.99
Profit Margin16.99%
RSI38.77
Shares Outstanding132.6M
ATR11.12
52-Week High495.55
Volume1,222,770
52-Week Low205.87
Book Value789.2M
P/B Ratio54.78
Upper Keltner350.68
P/S Ratio11.64
Lower Keltner300.65
Debt-to-Equity Ratio350.68
Next Earnings DateUnknown
Cash Surplus190.9M
Next Ex-Dividend DateUnknown
This innovative biotech stock has helped transform RNAi into an innovative new class of medicine. You have probably heard about RNA and mRNA innovation as the basis for the COVID-19 vaccine. This novel technology is set to shake up the medical world, and Alnylam is well-positioned to benefit from it.
Alnylam Pharmaceuticals Inc In Our Stock Scanner
As of Mar 13, 2026
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.